Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Selective Insurance
SIGI
$5.77B
| $1.8M | ﹤0.01% |
20,366
-8,841
| -30% | -$806K |
|
2277
ADMA Biologics
ADMA
$2.33B
| $1.8M | ﹤0.01% |
464,767
-3,949
| -0.8% | -$12.2K |
|
2278
PUT
ASML
ASML
$655B
| $1.8M | ﹤0.01% |
3,300
+2,500
| +313% | +$1.31M |
|
2279
WaFd
WAFD
$2.77B
| $1.8M | ﹤0.01% |
53,691
+21,008
| +64% | +$734K |
|
2280
CALL
Novavax
NVAX
$1.27B
| $1.8M | ﹤0.01% |
+175,000
| New | +$3.09M |
|
2281
CALL
Cleveland-Cliffs
CLF
$6.98B
| $1.8M | ﹤0.01% |
+111,500
| New | +$1.68M |
|
2282
Acuity Brands
AYI
$10.7B
| $1.8M | ﹤0.01% |
10,840
-3,794
| -26% | -$674K |
|
2283
Phillips Edison & Co
PECO
$5.24B
| $1.79M | ﹤0.01% |
56,242
-3,500
| -6% | -$108K |
|
2284
CNX Resources
CNX
$5.2B
| $1.79M | ﹤0.01% |
106,303
-314,074
| -75% | -$5.42M |
|
2285
Ashland
ASH
$3.32B
| $1.79M | ﹤0.01% |
16,627
+8,087
| +95% | +$852K |
|
2286
Trex
TREX
$4.93B
| $1.79M | ﹤0.01% |
42,201
+9,451
| +29% | +$429K |
|
|
GRIN
2287
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $1.78M | ﹤0.01% |
95,400
+58,708
| +160% | +$1.39M |
|
|
CLVT.PRA
2288
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $1.78M | ﹤0.01% |
+47,109
| New | +$1.98M |
|
|
TEF
2289
DELISTED
Telefonica
TEF
| $1.78M | ﹤0.01% |
499,736
-345,659
| -41% | -$1.21M |
|
2290
Standex International
SXI
$4.09B
| $1.78M | ﹤0.01% |
17,357
+1,986
| +13% | +$195K |
|
|
CPE
2291
DELISTED
Callon Petroleum Company
CPE
| $1.78M | ﹤0.01% |
47,916
-22,371
| -32% | -$919K |
|
2292
Urban One Class D
UONEK
$24.9M
| $1.77M | ﹤0.01% |
47,072
-8,013
| -15% | -$356K |
|
2293
Haemonetics
HAE
$3.86B
| $1.77M | ﹤0.01% |
22,477
+16,427
| +272% | +$1.32M |
|
2294
Ollie's Bargain Outlet
OLLI
$4.71B
| $1.76M | ﹤0.01% |
37,674
-16,963
| -31% | -$915K |
|
2295
PUT
Best Buy
BBY
$16.9B
| $1.76M | ﹤0.01% |
+22,000
| New | +$1.62M |
|
2296
Amphastar Pharmaceuticals
AMPH
$873M
| $1.76M | ﹤0.01% |
62,930
+7,426
| +13% | +$216K |
|
2297
Kyndryl
KD
$3.09B
| $1.76M | ﹤0.01% |
158,415
+2,805
| +2% | +$28.2K |
|
|
OPTU
2298
CALL
Optimum Communications Inc
OPTU
$315M
| $1.76M | ﹤0.01% |
+382,400
| New | +$1.88M |
|
2299
Fulton Financial
FULT
$4.67B
| $1.76M | ﹤0.01% |
104,392
-55,143
| -35% | -$966K |
|
2300
Buckle
BKE
$2.36B
| $1.76M | ﹤0.01% |
38,712
+1,861
| +5% | +$75.1K |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.